UTR Therapeutics plans to initiate a Phase 1 trial of UTRxM1-18 in patients with advanced c-MYC–driven tumors pending regulatory approvals. The company is also exploring translational and commercial ...

Cambridge-based startup CuspAI, which has just unveiled $100 million funding from global investors, was named Business of the ...

The biotechnology sector is entering a period of rapid growth and meaningful innovation. Global biotech revenue is expected to expand at roughly 13 to 14% annually over the next decade, moving from ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Half Year ResultsNewron presents H1 2025 results and provides business update 16.09.2025 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Newron presents H1 2025 ...

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...

Tallgrass Tech has donated $75,000 to Richland Community College to provide scholarships for engineering students.

Savvy investors do not always chase expensive stocks to find high-growth opportunities. In fact, some of the most exciting ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

University of Sheffield is inviting applications for BSc Biomedical course that starts from September 2026. The course ...